Memorial symptom assessment scale.

Expert Rev Pharmacoecon Outcomes Res

UMDNJ New Jersey Medical School, Section Hematology Oncology (111), VA New Jersey Healthcare System, 385 Tremont Avenue, East Orange, NJ 07018, USA.

Published: April 2004

Patients with advanced illnesses often have multiple symptoms. As interest in palliative care and interventions for symptom control increase, the ability to assess multiple symptoms has become more important. A number of instruments have been developed to meet this need in cancer patients. This article reviews the development and applications of a multidimensional instrument, the Memorial Symptom Assessment Scale. The Memorial Symptom Assessment Scale has 32 symptoms and three dimensions of frequency, severity, and distress. Shorter versions - The Memorial Symptom Assessment Scale Short Form (32 symptoms with one dimension) and the Condensed Memorial Symptom Assessment Scale (14 symptoms with one dimension), and a version for children aged 7-12 years, have also been developed. A distinctive feature is the summary subscales for physical distress, psychological distress, and The Global Distress Index. The Memorial Symptom Assessment Scale has proven useful in description of symptom epidemiology, the role of symptoms in pain, fatigue, and spirituality; as a predictor of survival, and in proxy assessments of pain. The Memorial Symptom Assessment Scale has been used in studies of cancer and AIDS patients, and patients with advanced medical illnesses. Possible future roles of instruments such as the Memorial Symptom Assessment Scale include use in clinical trials, for pharmacoeconomic analyses, definition of symptom clusters and symptom burden, the development of symptom outcome measures, symptom monitoring, and improving care for patients. Continued research is needed for the versions of the Memorial Symptom Assessment Scale and other symptom instruments in different populations and applications.

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.4.2.171DOI Listing

Publication Analysis

Top Keywords

memorial symptom
36
symptom assessment
36
assessment scale
36
symptom
15
memorial
9
assessment
9
scale
9
patients advanced
8
multiple symptoms
8
scale symptoms
8

Similar Publications

Background: In the phase 3 CANDOR trial (NCT03158688), daratumumab added to carfilzomib and dexamethasone (KdD) significantly prolonged progression-free survival relative to carfilzomib and dexamethasone (Kd) alone in previously treated patients with relapsed/refractory multiple myeloma (RRMM).

Materials And Methods: We present a post hoc analysis of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30-item module (EORTC QLQ-C30) and EORTC QLQ Myeloma 20-item module (EORTC QLQ-MY20) patient-reported outcome (PRO) measures from the CANDOR trial.

Results: Median (range) duration of observation for PROs was 18.

View Article and Find Full Text PDF

Effectiveness of enhanced group cognitive behaviour therapy for older adults (CBT-OA) with depression and anxiety: A replication study.

Int Psychogeriatr

March 2025

Social Policy and Advocacy, Department of Psychiatry, Dalhousie University, Room 6507 Abbie Lane Building, 5909 Veteran's Memorial Lane, Halifax, Nova Scotia B3H 1H9, Canada.

Objectives: Enhanced cognitive behavioural therapy for older adults (CBT-OA) modifies standard CBT to better address the needs of older adults, considering age-related impacts on learning. This study evaluated the effectiveness of Cassidy's manualized CBT-OA protocol (Cassidy, 2016a, 2016b) for late-life depression or anxiety in a larger sample at a different center.

Design: This retrospective observational study used a within-subject pre-/post-data design to evaluate the CBT-OA group for seniors with depression or anxiety.

View Article and Find Full Text PDF

Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer's disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations.

View Article and Find Full Text PDF

Behavioral clinical trials among cancer patients often fail to meet recruitment goals - especially for underrepresented groups. Comparing recruitment strategies on participant accrual and cost can inform the use of cost-effective recruitment strategies for enrollment of diverse populations of cancer patients. In this study, we compared social media, internet sites, and clinic-based recruitment on accrual, cost, and characteristics of cancer patients (i.

View Article and Find Full Text PDF

Multivisceral transplantation (MVT) is an extraordinarily complex surgical procedure that imposes significant physiological stress driven by hemodynamic instability, fluid shifts, and severe bleeding. These factors can profoundly affect cardiovascular function and increase the risk of complications. Stress cardiomyopathy (Takotsubo syndrome), a transient non-ischemic heart failure characterized by acute left ventricular dysfunction, is a recognized complication of major surgeries but has not previously been reported in the context of MVT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!